GALT   $2.7800000000000002  -2.11% Market Closed After Close 2.77 -0.36%

Galectin Therapeutics Inc
Total Cash 25.60M
totalCashPerShare 0.411
EBITDA
Total Debt 93.47M
quickRatio 1.751
currentRatio 1.867
Total Revenue
debtToEquity
Revenue/Share
ROA -1.03868
ROE
grossProfits
freeCashflow -20.36M
operatingCashflow -32.78M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 246.96M
forwardPE -1.6488096
floatShares 43.11M
sharesOutstanding 62.28M
sharesShort 5.06M
sharesShortPriorMonth 4.71M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.31%
heldPercentInstitutions 0.15%
Short Ratio help_outline 42.10%
shortPercentOfFloat 0.17%
impliedSharesOutstanding
bookValue -1.355
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -48.03M
trailingEps -0.76%
forwardEps -1.68%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.2 3Q 2024
institutionsCount 93
lastUpdated Sept. 21, 2024, 12:40 p.m.